Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

182023-04

VOLUNTARY ANNOUNCEMENT
182023-04

List of directors and their roles and functions
182023-04

RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR; PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR; CHANGE OF COMPOSITION OF BOARD COMMITTEES; RESIGNATION OF SUPERVISOR; AND PROPOSED APPOINTMENT OF SHAREHOLDERS’ REPRESENTATIVE SUPERVISOR
182023-04

POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 April 2023
042023-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
312023-03

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
272023-03

FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 17 APRIL 2023 OR AT ANY ADJOURNMENT THEREOF
272023-03

NOTICE OF EXTRAORDINARY GENERAL MEETING
272023-03

CONTINUING CONNECTED TRANSACTIONS IN RELATION TO ENTERING INTO FRAMEWORK LOAN AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING
202023-03

DATE OF BOARD MEETING
022023-03

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO FRAMEWORK LOAN AGREEMENT
012023-03

GRANT OF WAIVER FROM STRICT COMPLIANCE WITH THE MINIMUM PUBLIC FLOAT REQUIREMENT

5 6 7 8 9

The Enterprise OA